Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

September 28, 2004; 63 (6) Brief Communications

The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis

S. A. Morrow, C. A. Stoian, J. Dmitrovic, S. C. Chan, L. M. Metz
First published September 27, 2004, DOI: https://doi.org/10.1212/01.WNL.0000138572.82125.F5
S. A. Morrow
From the Department of Clinical Neurosciences (Dr. Morrow), University of Western Ontario, London, Ontario; and the Department of Clinical Neurosciences (Drs. Stoian and Metz) and Departments of Pharmacology and Therapeutics/Pathology and Laboratory Medicine (Mr. Dmitrovic and Dr. Chan), University of Calgary, Calgary, Alberta, Canada.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. A. Stoian
From the Department of Clinical Neurosciences (Dr. Morrow), University of Western Ontario, London, Ontario; and the Department of Clinical Neurosciences (Drs. Stoian and Metz) and Departments of Pharmacology and Therapeutics/Pathology and Laboratory Medicine (Mr. Dmitrovic and Dr. Chan), University of Calgary, Calgary, Alberta, Canada.
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Dmitrovic
From the Department of Clinical Neurosciences (Dr. Morrow), University of Western Ontario, London, Ontario; and the Department of Clinical Neurosciences (Drs. Stoian and Metz) and Departments of Pharmacology and Therapeutics/Pathology and Laboratory Medicine (Mr. Dmitrovic and Dr. Chan), University of Calgary, Calgary, Alberta, Canada.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. C. Chan
From the Department of Clinical Neurosciences (Dr. Morrow), University of Western Ontario, London, Ontario; and the Department of Clinical Neurosciences (Drs. Stoian and Metz) and Departments of Pharmacology and Therapeutics/Pathology and Laboratory Medicine (Mr. Dmitrovic and Dr. Chan), University of Calgary, Calgary, Alberta, Canada.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. M. Metz
From the Department of Clinical Neurosciences (Dr. Morrow), University of Western Ontario, London, Ontario; and the Department of Clinical Neurosciences (Drs. Stoian and Metz) and Departments of Pharmacology and Therapeutics/Pathology and Laboratory Medicine (Mr. Dmitrovic and Dr. Chan), University of Calgary, Calgary, Alberta, Canada.
MD FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis
S. A. Morrow, C. A. Stoian, J. Dmitrovic, S. C. Chan, L. M. Metz
Neurology Sep 2004, 63 (6) 1079-1080; DOI: 10.1212/01.WNL.0000138572.82125.F5

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
2973

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Oral prednisone 1might be a convenient, inexpensive alternative to IV methylprednisolone (IVMP) if the bioequivalent dose was known. We compared the total amount of steroid absorbed after 1250 mg oral prednisone vs 1 gram IVMP in 16 patients with multiple sclerosis (MS). At 24 hours, the mean area under the concentration-time curve (AUC), the main component of bioavailability, did not differ between groups (p = 0.122). This suggests that the amount of absorbed corticosteroid is similar after either steroid at these doses.

  • Received April 7, 2004.
  • Accepted in final form June 9, 2004.
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

  • Reply to Strupp
    • Luanne M Metz, University of Calgary, 12th Floor Neurosciences, Foothills Medical Centre, 1403-29th Street NW, Calgary, AB, T2N 2T9lmetz@ucalgary.ca
    Submitted November 18, 2004
  • The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis
    • Michael Strupp, Department of Neurology at the University of Munich, Klinikum Grosshadern, Marchioninistrasse 15, D-81377 Munich, GermanyMstrupp@nefo.med.uni-muenchen.de
    Submitted November 18, 2004
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Association of Long-term Exposure to Air Pollution and Dementia Risk: The Role of Homocysteine, Methionine, and Cardiovascular Burden

Dr. Fabricio Ferreira de Oliveira and Dr. Alan Cronemberger Andrade

► Watch

Related Articles

  • September 28 Highlight and Commentary

Alert Me

  • Alert me when eletters are published

Recommended articles

  • In This Issue
    September 28 Highlight and Commentary
    et al.
    Neurology, September 27, 2004
  • Articles
    Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS
    F. Sellebjerg, J. L. Frederiksen, P. M. Nielsen et al.
    Neurology, August 01, 1998
  • Article
    Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
    Hadas Stiebel-Kalish, Mark Andrew Hellmann, Michael Mimouni et al.
    Neurology: Neuroimmunology & Neuroinflammation, May 21, 2019
  • Articles
    A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis
    F. Sellebjerg, H. Schaldemose Nielsen, J.L. Frederiksen et al.
    Neurology, April 01, 1999
Neurology: 101 (20)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise